Wilmington, Mass.-based Accellent incurred a net loss of $3.3 million in the fourth quarter, an improvement from the $3.4 million loss during the same period last year. The company's net sales increased 1.1 percent over the fourth quarter 2011, though year-end sales were down 1.3 percent from last year.
Accellent manufactures and engineers medical devices for cardiology, endoscopy and orthopedic markets.
More Articles on Devices:
K2M Launches VENADO Biologic Bone Graft System
Medtronic Supports Efforts to Repeal Medical Device Tax
Tri-City Orthopaedic & Spine Institute Adds NavioPFS Robotic System
Accellent manufactures and engineers medical devices for cardiology, endoscopy and orthopedic markets.
More Articles on Devices:
K2M Launches VENADO Biologic Bone Graft System
Medtronic Supports Efforts to Repeal Medical Device Tax
Tri-City Orthopaedic & Spine Institute Adds NavioPFS Robotic System